Suppr超能文献

种间尺度转换与人体清除率预测:小分子药物与大分子药物的比较

Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.

作者信息

Huh Yeamin, Smith David E, Feng Meihau Rose

机构信息

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Xenobiotica. 2011 Nov;41(11):972-87. doi: 10.3109/00498254.2011.598582. Epub 2011 Sep 5.

Abstract

Human clearance prediction for small- and macro-molecule drugs was evaluated and compared using various scaling methods and statistical analysis. Human clearance is generally well predicted using single or multiple species simple allometry for macro- and small-molecule drugs excreted renally. The prediction error is higher for hepatically eliminated small-molecules using single or multiple species simple allometry scaling, and it appears that the prediction error is mainly associated with drugs with low hepatic extraction ratio (Eh). The error in human clearance prediction for hepatically eliminated small-molecules was reduced using scaling methods with a correction of maximum life span (MLP) or brain weight (BRW). Human clearance of both small- and macro-molecule drugs is well predicted using the monkey liver blood flow method. Predictions using liver blood flow from other species did not work as well, especially for the small-molecule drugs.

摘要

使用各种缩放方法和统计分析对小分子和大分子药物的人体清除率预测进行了评估和比较。对于经肾脏排泄的大分子和小分子药物,使用单物种或多物种简单异速生长法通常能很好地预测人体清除率。对于经肝脏消除的小分子药物,使用单物种或多物种简单异速生长缩放法时预测误差较高,并且似乎预测误差主要与肝脏提取率(Eh)低的药物有关。使用校正了最大寿命(MLP)或脑重量(BRW)的缩放方法可降低经肝脏消除的小分子药物人体清除率预测中的误差。使用猴肝血流量法能很好地预测小分子和大分子药物的人体清除率。使用其他物种的肝血流量进行的预测效果不佳,尤其是对于小分子药物。

相似文献

1
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.
Xenobiotica. 2011 Nov;41(11):972-87. doi: 10.3109/00498254.2011.598582. Epub 2011 Sep 5.
2
Interspecies scaling of biliary excreted drugs: a comparison of several methods.
J Pharm Sci. 2005 Apr;94(4):883-92. doi: 10.1002/jps.20313.
3
Interspecies scaling of biliary excreted drugs: prediction of human clearance and volume of distribution.
Drug Metabol Drug Interact. 2012;27(3):157-64. doi: 10.1515/dmdi-2012-0012.
4
Interspecies scaling of protein drugs: prediction of clearance from animals to humans.
J Pharm Sci. 2004 Jan;93(1):177-85. doi: 10.1002/jps.10531.
6
Interspecies scaling of biliary excreted drugs.
J Pharm Sci. 2002 Aug;91(8):1908-14. doi: 10.1002/jps.10174.
10
Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.
Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):767-775. doi: 10.1007/s13318-015-0305-2.

引用本文的文献

2
Species-Dependent Metabolism of a Covalent nsP2 Protease Inhibitor with In Vivo Antialphaviral Activity.
J Med Chem. 2025 May 22;68(10):10473-10485. doi: 10.1021/acs.jmedchem.5c00825. Epub 2025 May 12.
3
Integrating Pharmacokinetics and Quantitative Systems Pharmacology Approaches in Generative Drug Design.
J Chem Inf Model. 2025 May 26;65(10):4783-4796. doi: 10.1021/acs.jcim.5c00107. Epub 2025 May 9.
4
Prediction of first-in-human dose for new composition bee venom based on allometric scaling and pharmacokinetic modeling approach.
Transl Clin Pharmacol. 2025 Mar;33(1):27-39. doi: 10.12793/tcp.2025.33.e4. Epub 2025 Mar 24.
6
Active CNS delivery of oxycodone in healthy and endotoxemic pigs.
Fluids Barriers CNS. 2024 Oct 23;21(1):86. doi: 10.1186/s12987-024-00583-z.
7
An Evaluation of First-in-Human Studies for RNA Oligonucleotides.
Nucleic Acid Ther. 2024 Dec;34(6):276-284. doi: 10.1089/nat.2024.0036. Epub 2024 Sep 23.
8
Advances in Physiologically Based Pharmacokinetic (PBPK) Modeling of Nanomaterials.
ACS Pharmacol Transl Sci. 2024 Jul 12;7(8):2251-2279. doi: 10.1021/acsptsci.4c00250. eCollection 2024 Aug 9.

本文引用的文献

2
Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited.
Biopharm Drug Dispos. 2010 May;31(4):253-63. doi: 10.1002/bdd.708.
3
Body size and metabolic rate.
Physiol Rev. 1947 Oct;27(4):511-41. doi: 10.1152/physrev.1947.27.4.511.
4
Interspecies scaling of receptor-mediated pharmacokinetics and pharmacodynamics of type I interferons.
Pharm Res. 2010 May;27(5):920-32. doi: 10.1007/s11095-010-0098-6. Epub 2010 Mar 16.
6
Interspecies scaling of therapeutic monoclonal antibodies: initial look.
J Clin Pharmacol. 2009 Dec;49(12):1382-402. doi: 10.1177/0091270009337134. Epub 2009 Oct 16.
7
Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies.
Curr Drug Metab. 2009 Sep;10(7):661-91. doi: 10.2174/138920009789895499.
9
Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results.
J Clin Oncol. 2009 Jul 10;27(20):3346-53. doi: 10.1200/JCO.2008.19.9117. Epub 2009 May 18.
10
Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept.
Drug Metabol Drug Interact. 2009;24(1):57-81. doi: 10.1515/dmdi.2009.24.1.57.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验